The proposal clarifies state and federal oversight responsibilities for compounding pharmacies to improve the safety of compounded drugs, according to the report.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
More Articles on Sterile Compounding:
Balanced Solutions Compounding Pharmacy Recalls All Sterile Products
3 Compounding Pharmacies Recall Products in April
FDA Suggests Risk-Based Framework for Compounding Safety
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.